Hear from expert oncologists and pathologists how NGS-based comprehensive genomic profiling assays are changing the paradigm in oncology. On Demand recordings of ESMO Industry Satellite Symposium.


Phil Febbo
Chief Medical Officer
Illumina

 


Bernard Dogerde Spéville
Medical Oncologist
Fundación Jiménez Díaz

 


Wilko Weichert
Prof of Pathology
Technical University Munich

 

Details

Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
22 Sep 2020
Location
Europe
Topic
Oncology
Watch Now